Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAA50 | Q9GZZ1 | 2/20 | 0.80 |
| ▸ | CHAT | P28329 | 2/20 | 0.76 |
| ▸ | EP300 | Q09472 | 4/20 | 0.75 |
| ▸ | KAT5 | Q92993 | 2/20 | 0.75 |
| ▸ | AURKA | O14965 | 2/20 | 0.75 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.75 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.69 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1590966 | 1.00 | NAA50 (0.80) | NAA50CHATEP300KAT5AURKA | |
| SCHEMBL2510587 | 1.00 | NAA50 (0.80) | NAA50CHATEP300KAT5AURKA | |
| SCHEMBL188713 | 1.00 | NAA50 (0.80) | NAA50CHATEP300KAT5AURKA | |
| SCHEMBL14836951 | 1.00 | NAA50 (0.80) | NAA50CHATEP300KAT5AURKA | |
| SCHEMBL19181352 | 1.00 | NAA50 (0.80) | NAA50CHATEP300KAT5AURKA | |
| SCHEMBL2513740 | 1.00 | NAA50 (0.80) | NAA50CHATEP300KAT5AURKA | |
| SCHEMBL188145 | 1.00 | NAA50 (0.80) | NAA50CHATEP300KAT5AURKA | |
| SCHEMBL188242 | 1.00 | NAA50 (0.80) | NAA50CHATEP300KAT5AURKA | |
| SCHEMBL6061352 | 1.00 | NAA50 (0.80) | NAA50CHATEP300KAT5AURKA | |
| SCHEMBL31338605 | 1.00 | NAA50 (0.80) | NAA50CHATEP300KAT5AURKA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025073269-A1 | FABI ENZYME INHIBITOR AND USE THEREOF | 广州白云山医药集团股份有限公司白云山制药总厂 | 2025-04-10 | — | — | WO | disclosed |
| US-9673030-B2 | Computer readable storage mediums, methods and systems for normalizing chemical profiles in biological or medical samples detected by mass spectrometry | EMORY UNIVERSITY (US) | 2017-06-06 | — | — | US | disclosed |
| US-20110282587-A1 | COMPUTER READABLE STORAGE MEDIUMS, METHODS AND SYSTEMS FOR NORMALIZING CHEMICAL PROFILES IN BIOLOGICAL OR MEDICAL SAMPLES DETECTED BY MASS SPECTROMETRY | EMORY UNIVERSITY (US) | 2011-11-17 | — | — | US | disclosed |